These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9481038)

  • 1. Structural aspects of monoamine oxidase and its reversible inhibition.
    Wouters J
    Curr Med Chem; 1998 Apr; 5(2):137-62. PubMed ID: 9481038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indanones as high-potency reversible inhibitors of monoamine oxidase.
    Mostert S; Petzer A; Petzer JP
    ChemMedChem; 2015 May; 10(5):862-73. PubMed ID: 25820651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.
    Valente S; Tomassi S; Tempera G; Saccoccio S; Agostinelli E; Mai A
    J Med Chem; 2011 Dec; 54(23):8228-32. PubMed ID: 22017497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
    Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
    J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibition by selected anilide derivatives.
    Legoabe L; Kruger J; Petzer A; Bergh JJ; Petzer JP
    Eur J Med Chem; 2011 Oct; 46(10):5162-74. PubMed ID: 21899930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of monoamine oxidase B.
    Ramsay RR
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():81-9. PubMed ID: 26891670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of regions important for monoamine oxidase (MAO) A and B substrate and inhibitor selectivities.
    Shih JC; Chen K; Geha RM
    J Neural Transm Suppl; 1998; 52():1-8. PubMed ID: 9564602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor design for monoamine oxidases.
    Ramsay RR
    Curr Pharm Des; 2013; 19(14):2529-39. PubMed ID: 23116392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis.
    Cesura AM; Gottowik J; Lahm HW; Lang G; Imhof R; Malherbe P; Röthlisberger U; Da Prada M
    Eur J Biochem; 1996 Mar; 236(3):996-1002. PubMed ID: 8665924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives.
    Okaecwe T; Swanepoel AJ; Petzer A; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2012 Jul; 20(14):4336-47. PubMed ID: 22705191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase by indole and benzofuran derivatives.
    Prins LH; Petzer JP; Malan SF
    Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phe(208) and Ile(199) in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat.
    Geha RM; Chen K; Shih JC
    J Neurochem; 2000 Sep; 75(3):1304-9. PubMed ID: 10936214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives.
    Legoabe LJ; Petzer A; Petzer JP
    Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead.
    Tipton KF; Davey GP; McDonald AG
    Int Rev Neurobiol; 2011; 100():43-64. PubMed ID: 21971002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.
    Meiring L; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5498-502. PubMed ID: 24012182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors.
    Ramesh M; Dokurugu YM; Thompson MD; Soliman ME
    Comb Chem High Throughput Screen; 2017; 20(6):492-509. PubMed ID: 28294055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.